VIVE insider filings
VIVEVE MEDICAL, INC. — 31 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-01-05. Screen VIVE transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for VIVE between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.
Recent insider filings — VIVEVE MEDICAL, INC.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-01-05 | 4 | JORN DEBORA — Director | Grant/award (A): 36,000 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | Presnell Sharon Collins — Director | Grant/award (A): 36,000 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | Durbin Scott — Chief Executive Officer, Director | Grant/award (A): 360,000 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | Basta Steven L — Director | Grant/award (A): 72,000 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | Robbins Jim B — SVP, Finance & Administration | Grant/award (A): 57,000 (derivative) @ $0 | EDGAR |
| 2023-01-05 | 4 | Morris Arlene — Director | Grant/award (A): 36,000 (derivative) @ $0 | EDGAR |
| 2022-01-06 | 4 | JORN DEBORA — Director | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2022-01-06 | 4 | Presnell Sharon Collins — Director | Grant/award (A): 18,000 (derivative) @ $0 | EDGAR |
| 2022-01-06 | 4 | Durbin Scott — Chief Executive Officer | Grant/award (A): 258,000 (derivative) @ $0 | EDGAR |
| 2022-01-06 | 4 | Basta Steven L — Director | Grant/award (A): 48,000 (derivative) @ $0 | EDGAR |
| 2022-01-06 | 4 | Robbins Jim B — SVP, Finance & Administration | Grant/award (A): 42,000 (derivative) @ $0 | EDGAR |
| 2022-01-06 | 4 | Morris Arlene — Director | Grant/award (A): 22,000 (derivative) @ $0 | EDGAR |
| 2021-12-17 | 4 | Durbin Scott — Chief Executive Officer | Disposition to issuer (D): 2 @ $1.40 | EDGAR |
| 2021-12-17 | 4 | Basta Steven L — Director | Disposition to issuer (D): 28 @ $1.41 | EDGAR |
| 2021-12-17 | 4 | Robbins Jim B — SVP, Finance & Administration | Disposition to issuer (D): 36 @ $1.43 | EDGAR |
| 2021-06-25 | 4 | JORN DEBORA — Director | Grant/award (A): 51,700 (derivative) @ $0 | EDGAR |
| 2021-06-25 | 4 | Presnell Sharon Collins — Director | Grant/award (A): 39,000 (derivative) @ $0 | EDGAR |
| 2021-06-25 | 4 | Durbin Scott — Chief Executive Officer, Director | Grant/award (A): 655,300 (derivative) @ $0 | EDGAR |
| 2021-06-25 | 4 | Basta Steven L — Director | Grant/award (A): 116,200 (derivative) @ $0 | EDGAR |
| 2021-06-25 | 4 | Robbins Jim B — SVP, Finance & Administration | Grant/award (A): 104,700 (derivative) @ $0 | EDGAR |
| 2021-06-25 | 4 | Morris Arlene — Director | Grant/award (A): 51,700 (derivative) @ $0 | EDGAR |
| 2021-01-22 | 4 | JORN DEBORA — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2021-01-22 | 4 | Presnell Sharon Collins — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2021-01-22 | 4 | Durbin Scott — Chief Executive Officer | Grant/award (A): 243,000 (derivative) @ $0 | EDGAR |
| 2021-01-22 | 4 | Basta Steven L — Director | Grant/award (A): 50,000 (derivative) @ $0 | EDGAR |
| 2021-01-22 | 4 | Robbins Jim B — SVP, Finance & Administration | Grant/award (A): 39,000 (derivative) @ $0 | EDGAR |
| 2021-01-22 | 4 | Morris Arlene — Director | Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2020-10-30 | 4 | Presnell Sharon Collins — Director | Grant/award (A): 330,000 (derivative) @ $0 | EDGAR |
| 2020-09-22 | 4 | JORN DEBORA — Director | Grant/award (A): 165,000 (derivative) @ $0 | EDGAR |
| 2020-09-22 | 4 | Basta Steven L — Director | Grant/award (A): 165,000 (derivative) @ $0 | EDGAR |
| 2020-09-22 | 4 | Morris Arlene — Director | Grant/award (A): 165,000 (derivative) @ $0 | EDGAR |
Recent 8-K events — VIVEVE MEDICAL, INC.
Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2023-01-18 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2023-01-17 | 8-K | ? 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-12-15 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-12-02 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2022-12-01 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-11-23 | 8-K | 3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | EDGAR |
| 2022-11-10 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-10-04 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-09-27 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2022-09-22 | 8-K | 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=VIVE returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs